금융 뉴스 허브

Harley-Davidson stepping up U.S. production by bringing home Revolution Max platform

3 Reasons We Love RBC Bearings (RBC)

Since June 2021, the S&P 500 has delivered a total return of 74.9%. But one standout stock has more than doubled the market - over the past five years, RBC Bearings has surged 195% to $590.64 per shar ...

Veeco Instruments stock rallies 17% as follow-on order signals growing chip demand

SpaceX-Google cloud deal may point to Microsoft Azure upside: BNP

Plenty of Data Ahead of CPI, SPCX

Investors look toward tomorrow's Inflation Rate and the SpaceX IPO Friday, but we have lots of economic data out this morning: Small Business Index, Trade Balance and Existing Home Sales.

Dow Jones ETFs: Better Than S&P 500 & Nasdaq Now?

Rising rate fears are hurting tech-heavy indexes, but the Dow's value tilt and lower tech exposure may offer relative resilience.

CoreWeave Stock Tumbles 34% in a Year: What Should Investors Do Now?

CRWV falls 34%, but booming AI demand, a $99.4B backlog and NVIDIA ties keep investors debating its long-term potential.

How teens can turn a summer job into an extra $500,000 in savings when they’re older

Teens who don’t have summer jobs miss out on valuable work experience — and on prime years to invest their income.

BofA warns investors to take profits as 70% of the bank's bear market signals flash red

"Bear market signposts" should tell investors to take profits, according to Bank of America.

South Korean Won: Policy support aims to stabilise Won – Commerzbank

Commerzbank’s Charlie Lay explains that Korean authorities announced new measures to support the Korean Won, including tighter oversight of offshore FX derivatives, scrutiny of suspected misconduct, a ...

Jeff Bezos Is Chasing Elon Musk Into Africa to Build a Starlink Competitor

FEATURE SpaceX’s Starlink is, well, miles above its competition. That doesn’t mean competitors have given up. Jeff Bezos appears set on taking a slice of Elon Musk’s space pie. Amazon.com has select ...

Should You Add Myriad Genetics Stock to Your Portfolio Right Now?

MYGN is gearing up with oncology testing and steady product launches, backed by sound solvency, though foreign-exchange swings could weigh on results.